Clover Health Investments, Corp. (CLOV)
| Market Cap | 399.61M |
| Revenue (ttm) | 3.48B |
| Net Income (ttm) | -338.84M |
| Shares Out | 479.55M |
| EPS (ttm) | -0.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,612,403 |
| Open | 0.847 |
| Previous Close | 0.845 |
| Day's Range | 0.826 - 0.855 |
| 52-Week Range | 0.825 - 3.900 |
| Beta | 2.10 |
| Analysts | Sell |
| Price Target | 1.69 (+102.81%) |
| Earnings Date | May 8, 2023 |
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee. [Read more]
Financial Performance
In 2022, CLOV's revenue was $3.48 billion, an increase of 136.19% compared to the previous year's $1.47 billion. Losses were -$338.84 million, -42.35% less than in 2021.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for CLOV stock is "Sell." The 12-month stock price forecast is $1.69, which is an increase of 102.81% from the latest price.
News
3 SPACs to Sell Before They Go Bust in 2023
Over the past year, traders have looked for SPACs to sell amid a terrible slump in the sector. But the mood may be changing given the level of destruction across the sector.
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III's Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of...
Clover Health to Present at Barclays 2023 Global Healthcare Conference on March 14, 2023
FRANKLIN, Tenn., March 07, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving ...
Can Q4 Results Help Save Clover Health (CLOV) Stock?
Clover Health (NASDAQ: CLOV) stock is on the rise Tuesday thanks to the company's earnings report for the fourth quarter of 2022. One of the biggest factors that has investors celebrating is Clover H...
Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results
Q4 2022 Insurance MCR of 92.4% and FY 2022 Insurance MCR of 91.8%
Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023
FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
Clover Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
FRANKLIN, Tenn., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
CLOVER HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Clover Health Investments Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clover Health Investments Corp. (NASDAQ: CLOV) ...
Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023
FRANKLIN, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
FRANKLIN, Tenn., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
Clover Health Issues December 2022 Investor Frequently Asked Questions
FRANKLIN, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
Dr. Anna Loengard Joins Clover Health Board of Directors
FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
6 Penny Stocks to Sell Right Now
Penny stocks are much riskier than your average investment. After all, you don't typically have a share price below $5 without some problems, be it a failing business plan, poor execution by managemen...
7 Penny Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole
The explosive stock market rally seen on Nov. 10 may have invited some investors to start thinking this downturn is coming to a close. However, before you make the move from “risk-off” to “risk-on,” t...
Down 22.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Clover Health Investments, Corp. (CLOV)
The heavy selling pressure might have exhausted for Clover Health Investments, Corp. (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement amon...
Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Tops Revenue Estimates
Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 48.39% and 3.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead f...
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023
FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that for the 2021 measurement year, the ...
Clover Health to Report Third Quarter 2022 Financial Results on November 7, 2022
FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
Clover Health Debuts New Medicare Advantage Plans for 2023
FRANKLIN, Tenn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity fo...
Is Chamath Palihapitiya Giving Up on Clover Health (CLOV) Stock?
Clover Health (NASDAQ: CLOV) is losing its sponsor and must fly on alone. Chamath Palihapitiya, the “SPAC King” who brought CLOV stock public in early 2021 at about $16 per share (it's now at $1.86),...
7 Nasdaq Stocks to Sell Before They Die
As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500...
Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022
FRANKLIN, Tenn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
7 Meme Stocks for Investors to Take Seriously in 2022
Considering how markets have been moving so far this year, you might feel that meme stocks are a thing of the past. Once the markets take a bullish turn, though, expect the retail trading frenzy to fe...
Clover Health (CLOV) Stock Sinks on Leadership Change Announcement
Source: Wirestock Creators / Shutterstock Clover Health (NASDAQ: CLOV) stock is falling on Tuesday after the company announced changes are coming to its leadership team. The big news affecting Clover...